Find therapies in clinical trials near you – page 20

Study on the Long-Term Safety of Tavapadon for Patients with Parkinson's Disease

Study on the Long-Term Safety of Tavapadon for Patients with Parkinson's Disease

Study on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials

Study on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

Study on Botulinum Toxin Type A for Preventing Episodic Migraine in Adults

Study on Botulinum Toxin Type A for Preventing Episodic Migraine in Adults

Study of RVU120 for Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

Study of RVU120 for Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

Study on the Long-Term Safety and Effectiveness of Minzasolmin and Iodine Ioflupane (123I) in Patients with Parkinson's Disease

Study on the Long-Term Safety and Effectiveness of Minzasolmin and Iodine Ioflupane (123I) in Patients with Parkinson's Disease

Study on the Effectiveness and Safety of NT 201 Injections for Adults with Chronic Neuropathic Pain from Postherpetic Neuralgia or Nerve Injury

Study on the Effectiveness and Safety of NT 201 Injections for Adults with Chronic Neuropathic Pain from Postherpetic Neuralgia or Nerve Injury

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Study on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults

Study on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults

Phase 3 Study of ZIGAKIBART (BION-1301) in Adults with IgA Nephropathy

A Study Comparing Two Forms of Ocrelizumab Given Under the Skin in Patients with Multiple Sclerosis

A Study Comparing Two Forms of Ocrelizumab Given Under the Skin in Patients with Multiple Sclerosis